Semjon Manuel Willier
Impact in
- Oncology top 10%
- CAR-T cell therapy research
-
- Immune Cell Function and Interaction
Papers in
- Oncology 13
- CAR-T cell therapy research 13
- Co-authors
- Tobias F. Feuchtinger (17 shared papers)Franziska Blaeschke (12 shared papers)Theresa Kaeuferle (12 shared papers)Thomas G. P. Grünewald (5 shared papers)Elke Butt (3 shared papers)Dana Stenger (9 shared papers)Ramin Lotfi (3 shared papers)Judith Feucht (4 shared papers)
- Journals
- Blood (3 papers)Biology of the Cell (3 papers)Journal of Hematology & Oncology (2 papers)Molecular Therapy (2 papers)Leukemia (1 paper)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Semjon Manuel Willier
22 papers receiving 815 citations
Peers
Comparison fields: 5 of 60
- Oncology 493
- Immunology 191
- Hematology 56
- Molecular Biology 350
- Genetics 132
Countries citing papers authored by Semjon Manuel Willier
This map shows the geographic impact of Semjon Manuel Willier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Semjon Manuel Willier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Semjon Manuel Willier more than expected).
Fields of papers citing papers by Semjon Manuel Willier
This network shows the impact of papers produced by Semjon Manuel Willier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Semjon Manuel Willier. The network helps show where Semjon Manuel Willier may publish in the future.
Co-authors
The 25 scholars most cited alongside Semjon Manuel Willier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 146 | |
| 2 | 2018 | 139 | |
| 3 | 2013 | 128 | |
| 4 | 2019 | 109 | |
| 5 | 2020 | 63 | |
| 6 | 2020 | 40 | |
| 7 | 2019 | 33 | |
| 8 | 2011 | 32 | |
| 9 | 2021 | 26 | |
| 10 | 2013 | 25 | |
| 11 | 2020 | 24 | |
| 12 | 2022 | 17 | |
| 13 | 2022 | 11 | |
| 14 | 2022 | 10 | |
| 15 | 2020 | 9 | |
| 16 | 2019 | 8 | |
| 17 | 2025 | 4 | |
| 18 | 2020 | 2 | |
| 19 | 2020 | 2 | |
| 20 | 2024 | 2 |
About Semjon Manuel Willier
Semjon Manuel Willier is a scholar working on Oncology, Immunology, Molecular Biology, Genetics and Epidemiology, having authored 22 papers that have together received 832 indexed citations. Recurring topics across this work include CAR-T cell therapy research (13 papers), CRISPR and Genetic Engineering (2 papers), Cytomegalovirus and herpesvirus research (2 papers), Virus-based gene therapy research (2 papers), Nausea and vomiting management (2 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), Advancements in Semiconductor Devices and Circuit Design (2 papers) and Nanowire Synthesis and Applications (2 papers). The work is most often cited by research in Oncology (493 citations), Immunology (191 citations), Hematology (56 citations), Molecular Biology (350 citations) and Genetics (132 citations). Semjon Manuel Willier has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Tobias F. Feuchtinger, Franziska Blaeschke, Theresa Kaeuferle, Thomas G. P. Grünewald, Elke Butt, Dana Stenger, Ramin Lotfi, Judith Feucht, Michaela Döring and Andrew Kaiser. Their work appears in journals such as Blood, Biology of the Cell, Journal of Hematology & Oncology, Molecular Therapy and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.